ABCD2 TIA Risk Score
Score ABCD2 to predict 2-day stroke risk after transient ischaemic attack
Embed ABCD2 TIA Risk Score ▾
Add this tool to your website or blog for free. Includes a small "Powered by ToolWard" bar. Pro users can remove branding.
<iframe src="https://toolward.com/tool/abcd2-tia-risk-score?embed=1" width="100%" height="500" frameborder="0" style="border:1px solid #e2e8f0;border-radius:12px"></iframe>
Community Tips 0 ▾
No tips yet. Be the first to share!
Compare with similar tools ▾
| Tool Name | Rating | Reviews | AI | Category |
|---|---|---|---|---|
| ABCD2 TIA Risk Score Current | 4.3 | 2346 | - | Medical Diagnostics Reference |
| Peak Flow Percentage Predicted | 4.8 | 1610 | - | Medical Diagnostics Reference |
| CURB-65 Pneumonia Severity Score | 4.4 | 3100 | - | Medical Diagnostics Reference |
| MELD Score Liver Failure | 4.8 | 3581 | - | Medical Diagnostics Reference |
| Waterlow Pressure Ulcer Risk | 4.9 | 1846 | - | Medical Diagnostics Reference |
| HAS-BLED Bleeding Risk Score | 4.1 | 1419 | - | Medical Diagnostics Reference |
About ABCD2 TIA Risk Score
Stratify TIA Risk With the ABCD2 Score
A transient ischaemic attack is a medical emergency, not a minor event to be dismissed. Up to 20% of stroke patients have a preceding TIA, and the risk of stroke is highest in the first 48 hours. The ABCD2 TIA Risk Score calculator helps clinicians rapidly assess the short-term stroke risk following a TIA, guiding decisions about hospital admission, urgent investigation, and the intensity of secondary prevention measures.
Developed by Johnston and colleagues by combining two earlier prediction rules, the ABCD2 score has been validated in multiple populations and is recommended by stroke guidelines worldwide. This tool calculates the score instantly and provides the corresponding two-day and seven-day stroke risk percentages.
How the ABCD2 Score Is Calculated
Five clinical parameters are assessed. A - Age: 60 years or older scores 1 point. B - Blood pressure: systolic 140 mmHg or above and/or diastolic 90 mmHg or above at initial evaluation scores 1. C - Clinical features: unilateral weakness scores 2, speech disturbance without weakness scores 1, other symptoms score 0. D - Duration: 60 minutes or longer scores 2, 10-59 minutes scores 1, under 10 minutes scores 0. D - Diabetes: present scores 1.
Total scores range from 0 to 7. The tool categorises risk as low (0-3, approximately 1% two-day stroke risk), moderate (4-5, approximately 4% two-day risk), or high (6-7, approximately 8% two-day risk). Management recommendations are provided for each category.
Who Should Use This Tool?
Emergency physicians are the primary users, as TIA patients most commonly present to the emergency department. General practitioners evaluating patients who describe transient neurological symptoms use the score to determine urgency of referral. Stroke specialist nurses running TIA clinics use ABCD2 to triage referrals and allocate clinic appointments based on risk stratification.
The ABCD2 TIA Risk Score calculator is equally valuable for medical education, helping trainees learn the systematic approach to TIA risk assessment that guidelines recommend.
Clinical Decision-Making
High-risk patients (score 6-7) should be admitted for urgent investigation including brain imaging, carotid imaging, and cardiac evaluation, with initiation of antiplatelet therapy immediately. Moderate-risk patients (4-5) warrant urgent outpatient evaluation within 24-48 hours. Low-risk patients (0-3) can generally be seen in a dedicated TIA clinic within one week, though many guidelines now recommend that all TIA patients receive urgent evaluation regardless of score.
Limitations and Modern Context
The ABCD2 score has limitations. It does not incorporate imaging findings - a TIA patient with significant carotid stenosis or diffusion-weighted imaging changes is high risk regardless of their ABCD2 score. Some newer guidelines emphasise tissue-based definitions and imaging-guided management over purely clinical scores. Use ABCD2 as one component of a comprehensive assessment, not as the sole decision-making tool. It is most valuable in settings where immediate imaging is not available, helping clinicians quantify risk with bedside information alone while arranging definitive evaluation.